# Influenza A H3N2 Human Challenge Study in Healthy Adult Volunteers

> **NCT02594189** · PHASE1 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 49 (actual)

## Conditions studied

- Determine Minimally to Moderately Infective Dose (MMID) of Influenza A H3N2

## Interventions

- **OTHER:** Live recombinantly derived A/Bethesda/MM1/H3N2 virus

## Key facts

- **NCT ID:** NCT02594189
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-10-31
- **Primary completion:** 2017-11-01
- **Final completion:** 2017-11-01
- **Target enrollment:** 49 (ACTUAL)
- **Last updated:** 2019-12-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02594189

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02594189, "Influenza A H3N2 Human Challenge Study in Healthy Adult Volunteers". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02594189. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*